Skip to content
Sickle Cell Disease News logo
  • About sickle cell disease
    What is sickle cell disease?
    Causes
    Living with sickle cell disease
    Symptoms
    • Vaso-occlusive crisis
    Diagnosis
  • Treatments
    Approved treatments
    Experimental treatments
    Non-drug treatments
  • News
  • Columns
    Shaniqua’s Sickle Chronicles — Mary Shaniqua
    The Sickle Cell Crusader – Oluwatosin Adesoye
    Sickle Sagas — Dunstan Nicol-Wilson
    Sickle Unshackled – Sylvia Amuta
    Archived columns
    • Her Sickled Journey — Tito Oye
    • I Sickle Well — Somi Igbene
  • Forums
  • What can we help you find today?

December 9, 2021 News by Steve Bryson, PhD

IMR-687 Continuing to Lower VOCs and Hospitalizations in SCD Patients

IMR-687 (tovinontrine), an experimental oral therapy for sickle cell disease (SCD), reduced the rate of painful vaso-occlusive crisis (VOC), lowered hospitalization due to VOCs, and extended the time to a first VOC in SCD patients, according to new data from an open-label extension of a Phase 2 clinical trial.

Recent Posts

  • Level of physical activity tied to less pain, blood viscosity in SCD: Study
  • Celebrating ourselves is a way to promote sickle cell awareness
  • BEAM-101 shows sustained benefits as treatment for sickle cell
  • Attending a hematology conference as a sickle cell patient is empowering
  • World Sickle Cell Day events include walks, vigils, building lights
  • This World Sickle Cell Day, I’m grateful for UK advocacy groups
  • Sickle cell disease cell therapy named FDA orphan drug
  • Silence of sickle cell in children doesn’t always indicate mild disease
  • I can’t always identify the causes of a sickle cell crisis, despite my efforts
  • Oral inhibitor rilzabrutinib granted FDA orphan drug status for SCD


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: info@bionews.com
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2025 All rights reserved.